Aerpio Pharmaceuticals, Inc.
COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

Last updated:

Abstract:

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed. Combination therapy with antibodies and PK/PD data are also disclosed.

Status:
Application
Type:

Utility

Filling date:

29 May 2020

Issue date:

19 Nov 2020